Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Oregon - Page 2

Oregon

Doernbecher Children’s Hospital opened first pediatric intraoperative MRI facility on the West Coast
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Therapeutics

Doernbecher Children’s Hospital opened first pediatric intraoperative MRI facility on the West Coast

On Feb. 3, 2016, OHSU Doernbecher Childrenメs Hospital unveiled a 3-Tesla intraoperative magnetic resonance imaging machine that provides…

Read More Doernbecher Children’s Hospital opened first pediatric intraoperative MRI facility on the West CoastContinue

Living bacteria reported riding with earth’s upper air currents
Biology | Biotechnology | Environmental | Non-Profit Research

Living bacteria reported riding with earth’s upper air currents

On Jan. 11, 2016, National Aeronautics and Space Administration (NASA) research scientist David J. Smith reported finding that…

Read More Living bacteria reported riding with earth’s upper air currentsContinue

VGTI Florida turned over remaining assets to creditors: the City of Port St Lucie and the State of Florida
Biotechnology | Disease | Non-Profit Research | Therapeutics | Vaccine

VGTI Florida turned over remaining assets to creditors: the City of Port St Lucie and the State of Florida

On Oct. 1, 2015, the Vaccine & Gene Therapy Institute of Florida (VGTI Florida) announced plans to turn…

Read More VGTI Florida turned over remaining assets to creditors: the City of Port St Lucie and the State of FloridaContinue

VGTI Florida announced plans to close research institute
Biotechnology | Disease | Non-Profit Research | Therapeutics | Vaccine

VGTI Florida announced plans to close research institute

On Aug. 14, 2015, The Vaccine & Gene Therapy Institute of Florida (VGTI Florida) announced plans to close…

Read More VGTI Florida announced plans to close research instituteContinue

OHSU sets fundraising record by meeting $1 billion challenge from Nike co-founder and wife
Biotechnology | Non-Profit Research | Oncology | Radiology | Therapeutics

OHSU sets fundraising record by meeting $1 billion challenge from Nike co-founder and wife

On Jun. 24, 2015, Oregon Health and Science University (OHSU) announced it had met Nike co-founder Phil Knight…

Read More OHSU sets fundraising record by meeting $1 billion challenge from Nike co-founder and wifeContinue

OHSU research building named for noted molecular biologist
Biotechnology | Non-Profit Research | Therapeutics

OHSU research building named for noted molecular biologist

On Jun. 4, 2015, Oregon Health & Science University (OHSU) announced it had named a research building after…

Read More OHSU research building named for noted molecular biologistContinue

OHSU and  Pacific Northwest National Laboratory team up to accelerate biomedical discovery
Biotechnology | Diagnostics | Disease | Medical Device | Therapeutics

OHSU and Pacific Northwest National Laboratory team up to accelerate biomedical discovery

On May 6, 2015, Oregon Health & Science University (OHSU and the Department of Energy’s Pacific Northwest National…

Read More OHSU and Pacific Northwest National Laboratory team up to accelerate biomedical discoveryContinue

Casey Eye Institute researchers develop technology to address blindness
Biotechnology | Non-Profit Research | Ophthalmogy | Therapeutics

Casey Eye Institute researchers develop technology to address blindness

On Apr. 24, 2015, researchers led by David Huang, M.D., Ph.D. at Oregon Health Sciences University’s (OHSU) Casey…

Read More Casey Eye Institute researchers develop technology to address blindnessContinue

Genentech announced plans to invest $125 million in Hillsboro facility
Biotechnology | Diagnostics | Disease | Therapeutics

Genentech announced plans to invest $125 million in Hillsboro facility

On Mar. 26, 2015, Genentech, a member of the Roche Group, announced plans to invest more than $125…

Read More Genentech announced plans to invest $125 million in Hillsboro facilityContinue

Pacific Northwest National Laboratory constructed new chemistry facility
Chemical | Non-Profit Research

Pacific Northwest National Laboratory constructed new chemistry facility

On Mar. 19, 2015, a contract was awarded to DGR Grant Construction of Richland, Washington, to build a…

Read More Pacific Northwest National Laboratory constructed new chemistry facilityContinue

Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach
Biotechnology | Life Science History | Oncology

Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreach

On Nov. 5, 2014, the Ford Family Foundation announced a $5 million grant to the Knight Cancer Institute…

Read More Ford Family Foundation awarded $5 million grant to advance the OHSU Knight Cancer Institute’s rural outreachContinue

OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants
Biotechnology | Infectious Disease | NIH | Non-Profit Research | Vaccine

OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvants

On Oct. 20, 2014, Oregon Health & Science University’s Vaccine & Gene Therapy Institute (OHSU) announced it was…

Read More OHSU, partners Kineta, U of Washington, VGTI Florida awarded $10 million NIH contract to develop new vaccine adjuvantsContinue

OHSU scientist awarded $25 million grant to further HIV vaccine research
Biotechnology | Diagnostics | HIV | Infectious Disease | Therapeutics | Vaccine

OHSU scientist awarded $25 million grant to further HIV vaccine research

On Sept. 3, 2014, Oregon Health & Science University (OHSU) announced it had been awarded a $25 million…

Read More OHSU scientist awarded $25 million grant to further HIV vaccine researchContinue

OHSU Knight Cancer Challenge announced $100 million gift
Biotechnology | Diagnostics | Medicine | Non-Profit Research | Oncology | Radiology | Therapeutics

OHSU Knight Cancer Challenge announced $100 million gift

On Jul. 28, 2014, OHSU announced it has received a $100 million gift from an unnamed donor who…

Read More OHSU Knight Cancer Challenge announced $100 million giftContinue

OHSU Collaborative Life Sciences Building launched new era in health and science research and education
Biotechnology | Medicine | Non-Profit Research | Oncology | Therapeutics

OHSU Collaborative Life Sciences Building launched new era in health and science research and education

On Jun. 26, 2014, a $300 million building opened in Portland is shared by Portland State University and Oregon…

Read More OHSU Collaborative Life Sciences Building launched new era in health and science research and educationContinue

OHSU announced creation of new embryonic stem cell and gene therapy center
Biotechnology | Stem Cell | Therapeutics

OHSU announced creation of new embryonic stem cell and gene therapy center

On Mar. 5, 2014, Oregon Health & Science University (OHSU) announced the creation of the Center for Embryonic…

Read More OHSU announced creation of new embryonic stem cell and gene therapy centerContinue

Thermo Fisher announced it has completed its acquisition of Life Technologies (formerly Microprobe)
Biotechnology | Diagnostics

Thermo Fisher announced it has completed its acquisition of Life Technologies (formerly Microprobe)

On Feb. 3, 2014, Thermo Fisher announced it had completed its acquisition of Life Technologies for $76.13 in…

Read More Thermo Fisher announced it has completed its acquisition of Life Technologies (formerly Microprobe)Continue

Bend Research was acquired by Capsugel
Biotechnology | CRO | Pharmaceutical

Bend Research was acquired by Capsugel

On Oct. 1, 2013, Capsugel announced it had completed its acquisition of Bend Research. The company was founded…

Read More Bend Research was acquired by CapsugelContinue

Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challenge
Biotechnology | Non-Profit Research | Oncology | Radiology | Therapeutics

Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challenge

On Sept. 21, 2013, philanthropists Phil and Penny Knight pledged $500 million to kick-start a $1 billion cancer…

Read More Nike co-founder Phil Knight and wife Penny issued $1 billion cancer challengeContinue

OHSU launched a $25 million clinical and translational science initiative against lethal, hard-to-treat pancreatic disease
Life Science History

OHSU launched a $25 million clinical and translational science initiative against lethal, hard-to-treat pancreatic disease

On Sept. 12, 2013, Oregon Health & Science University (OHSU) announced it had received two gifts totaling $25…

Read More OHSU launched a $25 million clinical and translational science initiative against lethal, hard-to-treat pancreatic diseaseContinue

The OHSU/OSU Collaborative Life Sciences Building and Skourtes Tower ‘Topped Out’
Dentistry | Non-Profit Research

The OHSU/OSU Collaborative Life Sciences Building and Skourtes Tower ‘Topped Out’

On Jan. 17, 2013, E Dunn Construction announced it had topped out the OHSU/OUS Collaborative Life Sciences Building…

Read More The OHSU/OSU Collaborative Life Sciences Building and Skourtes Tower ‘Topped Out’Continue

Oregon Health & Science University Received $125 Million Gift From Nike Founder
Biotechnology | Diagnostics | Medical Device | Medicine | Non-Profit Research | Therapeutics

Oregon Health & Science University Received $125 Million Gift From Nike Founder

On Sept. 19, 2012, Oregon Health & Science University (OHSU) in Portland announced that it had received a…

Read More Oregon Health & Science University Received $125 Million Gift From Nike FounderContinue

Grateful family left more than $10 million to support OHSU
Biotechnology | Medicine | Non-Profit Research | Therapeutics

Grateful family left more than $10 million to support OHSU

On Sept. 10, 2012, Oregon Health Science University (OHSU) announced the estate of Garthe and Grace Brown designated…

Read More Grateful family left more than $10 million to support OHSUContinue

OHSU’s Oregon National Primate Research Center opened dedicated lab space
Biotechnology | Medicine | Therapeutics

OHSU’s Oregon National Primate Research Center opened dedicated lab space

On Mar. 27, 2012, the Oregon National Primate Research Center at OHSU dedicated a new home for its…

Read More OHSU’s Oregon National Primate Research Center opened dedicated lab spaceContinue

OHSU-led consortium awarded $21 million grant to study alcoholism, stress
Biotechnology | Neurology | Therapeutics

OHSU-led consortium awarded $21 million grant to study alcoholism, stress

On Mar. 8, 2012, the National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a five-year, $21 million…

Read More OHSU-led consortium awarded $21 million grant to study alcoholism, stressContinue

Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu
Biotechnology | Diagnostics | Influenza | Non-Profit Research | Therapeutics | Vaccine

Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the flu

On Feb. 21, 2012, as part of a national collaboration, Oregon Health & Science University researchers were studying…

Read More Mice bred to more closely resemble a genetic variation in humans help target an annual outbreak: the fluContinue

The FDA approved Gleevec for Five Rare, Life-Threatening Disorders
Biotechnology | FDA | Non-Profit Research | Oncology | Therapeutics

The FDA approved Gleevec for Five Rare, Life-Threatening Disorders

On Jan. 31, 2012, the U.S. Food and Drug Administration (FDA) granted Gleevec (imatinib) regular approval for use…

Read More The FDA approved Gleevec for Five Rare, Life-Threatening DisordersContinue

Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring Award
Biotechnology | Therapeutics

Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring Award

In 2012, Samantha Lewis, a senior in the Oregon State University College of Science, won the Society for…

Read More Samantha Lewis at OSU won the Society for Molecular Biology and Evolution Undergraduate Diversity Mentoring AwardContinue

The OHSU/OSU Collaborative Life Sciences Building broke ground
Biotechnology | Dentistry | Diagnostics | Medicine | Non-Profit Research | Therapeutics

The OHSU/OSU Collaborative Life Sciences Building broke ground

On Oct. 13, 2011, the OHSU/OSU Collaborative Life Sciences Building (CLSB) broke ground on the new $295 million…

Read More The OHSU/OSU Collaborative Life Sciences Building broke groundContinue

Synthetech was acquired by W R Grace
Chemical

Synthetech was acquired by W R Grace

On Nov. 18, 2010, W. R. Grace & Co. announced it had completed its acquisition of Albany-based Synthetech,…

Read More Synthetech was acquired by W R GraceContinue

Page navigation

Previous PagePrevious 1 2 3 4 … 6 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search